Source: https://patents.google.com/patent/WO2008108901A1/en
Timestamp: 2019-07-19 03:13:42
Document Index: 106856299

Matched Legal Cases: ['art 10', 'art 10', 'art 10', 'art 10', 'art 10', 'art 10', 'art 10', 'art 10']

WO2008108901A1 - Chronically-implantable active fixation medical electrical leads and related methods for non-fluoroscopic implantation - Google Patents
WO2008108901A1
WO2008108901A1 PCT/US2007/089087 US2007089087W WO2008108901A1 WO 2008108901 A1 WO2008108901 A1 WO 2008108901A1 US 2007089087 W US2007089087 W US 2007089087W WO 2008108901 A1 WO2008108901 A1 WO 2008108901A1
PCT/US2007/089087
WO2008108901A8 (en
2006-12-28 Priority to US60/882,425 priority Critical
2006-12-28 Priority to US88243506P priority
2006-12-28 Priority to US88241306P priority
2006-12-28 Priority to US60/882,413 priority
2006-12-28 Priority to US60/882,428 priority
2006-12-28 Priority to US60/882,431 priority
2006-12-28 Priority to US60/882,435 priority
2006-12-28 Priority to US60/882,420 priority
2007-04-18 Priority to US60/912,610 priority
2007-12-28 Application filed by Medtronic, Inc filed Critical Medtronic, Inc
2007-12-28 Priority claimed from EP07870059A external-priority patent/EP2136706A1/en
2008-09-12 Publication of WO2008108901A1 publication Critical patent/WO2008108901A1/en
2010-02-18 Publication of WO2008108901A8 publication Critical patent/WO2008108901A8/en
Bio-impedance may be used for navigation systems to chronically implant pacing and defibrillation leads in the heart using a non-fluoroscopic position sensing unit (PSU), such as a modified LocaLisa® system from Medtronic Inc., which allows for variable frequency sampling of the position of electrode of a catheter. The PSU injects small AC signals via surface electrodes in three orthogonal axes, each on a slightly different frequency (e.g., near 30 KHz). Indwelling electrodes electrically connected to the PSU resolves the magnitude of induced voltage for each of the three frequencies, thus measuring voltage for each of the three axes. Voltages are divided by induced current to yield impedance in each axis for each electrode. Impedance is proportional to position within the body. Such a system requires that a conductive material, such as a retractable helical tip-electrode, be exposed during implantation. Since the tip is retracted during implantation, this disclosure provides a modified distal portion employing at least one aperture (or 'window') for fluid exposure of the helix-electrode and a deployable internal sleeve for covering the aperture(s) when the helix-electrode is extended.
CHRONICALLY-IMPLANTABLE ACTIVE FIXATION MEDICAL
ELECTRICAL LEADS AND RELATED METHODS
FOR NON-FLUOROSCOPIC IMPLANTATION
This non- provisional U.S. patent application claims the benefit of the filing of the following provisional U.S. patent applications; namely: application serial number 60/912,610; 60/882,420; 60/882,431; 60/882,435; 60/882,425; 60/882,428; 60/882,413 and each said application is hereby incorporated herein by reference in their respective entireties as if fully set forth herein.
BACKGROUND OF THE INVENTION Prior art techniques relating to the instant invention include U.S. Pat. Nos.
5,983,126 and 5,697,377 to Wittkampf the contents of which are incorporated herein by reference. Wittkampf s work is based on orthogonal electric fields generated by the application of electrical energy to patches placed on the body. A system distributed by Medtronic, Inc., the LocaLisa® brand intra-corporeal navigation system, is at least partially based upon Wittkampf s work. In such a system, electrodes coupled to the skin of a subject provide orthogonal electrical fields (electrical potential-based fields) are used to locate the position of one or more electrodes coupled to an acutely implantable lead deployed within an organ or anatomical feature of interest. However, neither the system nor the acutely implantable lead provides the ability to precisely position and chronically implant a medical electrical lead, such as a cardiac pacing lead. SUMMARY OF THE INVENTION
The IsF system utilizes the body's conductivity to determine electrode position. A Position Sensing Unit (PSU) introduces three small alternating currents (AC), each approximately 30 KHz into the body in three axes. Electrical currents are introduced through three pairs of patches applied to the patient's body surface. Electrodes on indwelling catheters are connected to the PSU. Signals from the three AC signal sources are resolved in the PSU and sent to a computer via serial I/O (SIO) communications channel. The IsF system monitors the SIO communications and processes position data from the PSU to provide a position display. The PSU has a foot pedal for the implanting physician. When the foot pedal is depressed, IsF prompts the physician with a list of labels to landmark the present location of the catheter electrodes. A joystick for the physician is used to select labels for foot pedal marked landmarks. The IsF system is designed to be used with indwelling electrodes on catheters and can be designed to visualize locations via leads having one or multiple electrodes. The IsF system can utilize a reference electrode placed at the xiphoid process (also known as the cardiac notch) allows IsF to display the patient midline which provides additional visual cues to a user during collection of electrode data. In one form of the present invention, for example, a modified Medtronic model 5076 or a model 3830 endocardial pacing lead can be chronically implanted following collection of data of the electrode locations. For example, a model 5076 lead can be deployed into a desired cardiac chamber (e.g., via a Medtronic SelectSite™ model 6226DEF deflectable sheath catheter for a ventricular chamber and a model C304-S59 for the right atrial chamber). An Edwards Lifesciences brand Swan-Ganz Bipolar Pacing Catheter (REF: D97120F5) can be used for exploration leading to placement of the ventricular pacing lead. Note that the Edwards balloon catheter is 5F outer diameter, thus requiring the model of deflectable sheath listed above. The balloon catheter has two electrodes, one distal and one proximal to the balloon used for presenting electrograms.
Of course, according to the invention other suitable combinations of modified active fixation-type pacing or defibrillation cardiac pacing leads, introducer instruments, and exploration catheters can be used per the present invention.
A pacemaker or ICD (e.g., a single, dual or triple chamber device) optionally having CRT delivery capability can utilize electrode configured per the present invention.
If a single chamber ventricular pacemaker is to be implanted, the steps for implantation of the atrial are omitted. If a single chamber atrial pacemaker is to be implanted, exploration steps using the balloon catheter for the ventricular lead will be followed to provide three dimensional landmarks. Once obtained and the balloon deflated, a ventricular lead will not be introduced. The procedure will then progress to introduction of the atrial lead.
A Medtronic brand implantable pulse generator (pacemaker) including chamber capture management can be used to track pacing thresholds on an ambulatory basis post implant to make the chronically lead remains fixed to the desired locations. Such pacemakers include without limitation the EnPulse, Adapta, Versa, and Sensia brand IMDs. Display of physiological data shall be with instrumentation provided by the investigating center. These data can include the electrocardiogram (ECG), electrograms (EGM) from indwelling catheter electrodes, and pressure of an inflated balloon disposed on a distal portion of an electrode-bearing elongated structure. DESCRIPTION OF THE DRAWINGS
FIG. 2 is a simplified block diagram of an embodiment of IMD circuitry and associated leads that may be employed in the system of FIG. 1 to enable selective therapy delivery and monitoring in one or more heart chamber. FIG. 3 is a simplified block diagram of a single monitoring and pacing channel for acquiring pressure, impedance and cardiac EGM signals employed in monitoring cardiac function and/or delivering therapy, including pacing therapy, in accordance with embodiments of the invention.
FIGS. 6(a) - (c) show cross-sectional views of endocardial and epicardial electrode locations for monitoring cardiac tissue in accordance with certain embodiments of the invention.
DETAILED DESCRIPTION OF ILLUSTRATED EMBODIMENTS The following detailed description should be read with reference to the drawings, in which like elements in different drawings are numbered identically. The drawings depict selected embodiments and are not intended to limit the scope of the invention. It will be understood that embodiments shown in the drawings and described below are merely for illustrative purposes, and are not intended to limit the scope of the invention as defined in the claims. Certain embodiments of the invention may provide a non-invasive technique for monitoring the position, movement, and/or geometric characteristics of internal body tissue, such as cardiac muscle tissue. For example, such information may enhance the ability to assess certain parameters (e.g., parameters related to cardiac performance), and may also affect therapy delivery decisions. In one particular embodiment, for example, measuring the position and movement of leads appropriately placed in the heart for long- term therapy delivery.
An embodiment of the invention includes a system for monitoring movement of internal body tissue, such as cardiac muscle tissue. The system may include one or more pairs of surface electrodes disposed about the body tissue capable of supplying an electric field through the body tissue between the surface electrodes. The position and movement of the body tissue may be detected by coupling an internal electrode to the body tissue, and measuring a voltage induced therein, the induced voltage being a function of the position between the two surface electrodes. The voltage induced on the internal electrode may be provided to the system as a position signal for monitoring and/or recording. In certain embodiments, position signals corresponding to the movement of one or more internal electrodes may be used to determine measures of cardiac performance, including systolic and diastolic cardiac function. In certain embodiments, a second and third pair of surface electrodes may be used to generate position information signals with respect to three axes of geometry to thereby provide a three-dimensional position signal.
In certain embodiments of the invention, the system may be used in conjunction with an implantable cardiac rhythm management/monitoring device. An implantable medical device (IMD) may be coupled to standard implantable leads (e.g., cardiac pacing leads), which may serve as the internal electrodes of the system for monitoring movement of body tissue. In such an embodiment, movement of body tissue (e.g., cardiac muscle tissue) may cause corresponding movement of the implantable leads. The implantable leads, when exposed to the electric field signals, may have a voltage induced, which may be sensed by the IMD and either stored in memory, processed, or telemetered out to a programmer for further processing. In some embodiments, the IMD may process location information and/or determine measures of cardiac performance, and may store such information for later retrieval. In some embodiments, the telemetered voltage signals may be processed by a programming system or computer to generate position information, as well as to compute various measures of cardiac performance, such as left ventricular dimension, for example. FIG. 1 is a schematic representation of an implantable medical device (IMD) 14 that may be used in accordance with certain embodiments of the invention. The IMD 14 may be any device that is capable of measuring hemodynamic parameters (e.g., blood pressure signals) from within a ventricle of a patient's heart, and which may further be capable of measuring other signals, such as the patient's electrogram (EGM). In FIG. 1, heart 10 includes the right atrium (RA), left atrium (LA), right ventricle (RV), left ventricle (LV), and the coronary sinus (CS) extending from the opening in the right atrium laterally around the atria to form the great vein.
FIG. 2 depicts a system architecture of an exemplary multi-chamber monitor/sensor 100 implanted into a patient's body 11 that provides delivery of a therapy and/or physiologic input signal processing. The typical multi-chamber monitor/sensor 100 has a system architecture that is constructed about a microcomputer-based control and timing system 102 which varies in sophistication and complexity depending upon the type and functional features incorporated therein. The functions of microcomputer-based multi- chamber monitor/sensor control and timing system 102 are controlled by firmware and programmed software algorithms stored in RAM and ROM including PROM and EEPROM and are carried out using a CPU or ALU of a typical microprocessor core architecture.
Examples illustrated in FIG. 2 include pressure and volume sensors, but could include other physiologic or hemodynamic sensors.
FIG. 3 schematically illustrates one pacing, sensing and parameter measuring channel in relation to one heart chamber. A pair of pace/sense electrodes 140, 142, a pressure sensor 160, and a plurality, e.g., four, impedance measuring electrodes 170, 172,
174, 176 are located in operative relation to the heart 10.
The set of impedance electrodes 170, 172, 174 and 176 is coupled by a set of conductors 178 and is formed as a lead that is coupled to the impedance power supply and signal processor 180. Impedance-based measurements of cardiac parameters such as stroke volume are known in the art, such as an impedance lead having plural pairs of spaced surface electrodes located within the heart 10. The spaced apart electrodes can also be disposed along impedance leads lodged in cardiac vessels, e.g., the coronary sinus and great vein or attached to the epicardium around the heart chamber. The impedance lead may be combined with the pace/sense and/or pressure sensor bearing lead. FIG. 4 shows a schematic illustration of a plurality of surface electrodes (e.g., electrode patches) applied to a patient's skin to generate electric fields that pass through body tissue of interest, such as heart 10, according to certain embodiments of the invention. The electric fields may be generated by applying a voltage across a pair of generally planar surface electrodes (e.g., patch electrodes 202a, 202b, 204a, 204b, 206a, and 206b), which may be applied externally to a patient's skin, or may be implanted subcutaneously according to certain embodiments. In some embodiments, the voltage for generating the electric fields may be supplied by a small device worn by a patient, for example, and applied to the planar electrodes.
As shown in FIG. 4, patch electrodes 202a and 202b may be positioned to generate an electric field that travels between electrodes 202a and 202b, defining an axis 212. Thus, the position of an electrode along axis 212 (and hence, movement with respect to axis 212) may be determined by measuring a voltage induced on the electrode as a function of time. An electrode (or electrodes) coupled to the heart 10 (or portions thereof) may therefore provide position and movement information with respect to axis 212. Similarly, electrodes 204a and 204b may provide an electric field through the heart 10 along axis 214, and electrodes 206a and 206b may provide an electric field through the heart along axis 216. As shown, axes 212, 214, and 216 may be orthogonal axes to describe three-dimensional position information. In certain embodiments, one or two axes may be employed to describe one- and two-dimensional position information, respectively.
FIG. 5 shows an exemplary 3 -lead system, having electrode locations in the right ventricle, the right atrium and in the left ventricle (e.g., via the coronary venous circulation) of a patient's heart 10. In general, the lead electrodes can be positioned such that they span a particular dimension of interest, which may provide monitoring of heart chamber characteristics throughout the cardiac cycle, according to certain embodiments. Voltage measurements may be taken relative to a stable reference electrode, such as the can electrode of IMD 14, or a stable reference electrode on a lead located within the heart 10, for example. At any given time, each lead electrode will have associated x, y, and z position coordinates. By applying electric fields to orthogonal pairs of surface electrodes placed on the patient, each implanted electrode will produce sensed voltages (Vx, Vy, Vz) that reflect the voltage difference between the lead electrode and the reference as a function of lead electrode position along each orthogonal axis. Assuming homogeneous body conductance, each voltage will be linearly related to the lead electrode position in each orthogonal axis. The location of the implanted electrodes in each of the 3 axes can thereby be determined.
A simple calibration scheme could use the bipolar electrode configuration with known interelectrode distance on any of the leads. Standard IPG bipolar leads can be used for that purpose. Calibration can be performed automatically on a regular basis to account for changing tissue sensitivities and changes in lead orientation. In another deployment scheme, two or more electrodes could be deployed on the outer surface of the myocardium and then connected to the IPG.
FIGS. 6(a) - (c) show cross-sectional views of endocardial and epicardial electrode locations for monitoring cardiac tissue in accordance with certain embodiments of the invention. Some electrode locations may be positioned close to the patch electrodes on the skin. If the skin patches are not sufficiently large, the electric field lines may be slightly curved leading to a minor error in the measurement. In the preferred embodiment, the skin electrodes in the z-direction in FIG. 1 are larger than the skin electrodes in the other 2 directions to account for the proximity of the z-electrodes to the heart.
FIG. 7 is a two-dimensional plot illustrating the calculation of position information according to an embodiment of the invention. Techniques to generate electric fields from a small wearable device capable of delivering frequencies in the range 5-50 kHz on three essentially orthogonal axes: The device should be battery operated and be capable of extended use if used in an ambulatory setup. Calibration techniques to convert voltage measurements to position information: In one embodiment, at least one lead will have a bipolar configuration (tip-ring) with known inter-electrode distance. By placing the electrodes in the electric field, each electrode will sense voltages from the three axes. The magnitude of the voltage sense in each direction is proportional to the distance from one of the patches generating the field in that direction. The constant of proportionality is related to the medium and the field strength. In one embodiment, the three orthogonal fields are identical and the calibration step can be done with a single measurement. In this system, the implanted device has no information regarding the current for each of the electrodes unless it is coded into the external generator and so transmitted to the implanted device. If the external generator regulates the applied voltage to each of the three pair of patch electrodes, such that current through each of the three is equal, then a corresponding movement by each electrode will generate the same voltage change for equivalent position change in each axis. In this manner, one millimeter of movement in any of the x, y, or z directions will produce the same magnitude voltage change. FIGS. 8A-D are elevational views schematically depicting a prior art (Medtronic model 5076) retractable helix lead and an embodiment according to the present invention. At least one aperture, or window, 9 is formed in a lateral portion of the proximal end portion of the lead adjacent to a part of the helix 10 (when retracted). A corresponding cover structure (e.g., a sleeve member) 7 couples to a base portion 5 of the helix 10' such that when the helix 10' is retracted the metallic or conductive helix 10' can be imaged using electropotential (or electromagnetic) fields such as via a derivative of a LocaLisa® brand non- fluoroscopic imaging system. The sleeve 7 effectively seals and covers the aperture(s) 9 when the helix 10' is deployed following implantation and thus avoids possible contamination or ingress of body fluids over the long term. FIG. 9 is a side, cut away view through the distal end of pacing lead according to the present invention. At the very distal end of the lead, a sharpened helix 10 is located, which extends distal to the distal portion of the lead body. Helix 10 is preferably conducted of an inert, biocompatible metal such as MP35N alloy, Elgiloy alloy, or a platinum alloy. As illustrated, helix 10' is generally a conical, tapered helix and the sharpened, distal end 12' of the helix is located intersecting the central axis of the lead.
The lead is provided with an electrode head member 14', to which helix 10' is mounted by means of a plastic sleeve 16' in which the proximal end of helix 10' is embedded. Sleeve 16' may be fabricated of polyurethane or silicone rubber. Thus, at least one aperture, or window, 9 is formed in a lateral portion of the proximal end portion of the lead adjacent to a part of the helix 10 (when retracted). A corresponding cover structure 7 couples to a base portion 5 of the helix 10' as previously described.
Located within head member 14' is an electrode chamber 18' which contains a monolithic controlled release device impregnated with a glucocorticosteroid, delivered to the distal end of the electrode head member 14' by means of a longitudinal bore 22', which may be filled with a porous, sintered structure to control elution rate of the steroid.
Details of construction related to such electrodes are found in U.S. Pat. No. 4,506,680, issued to Stokes, incorporated herein by reference in its entirety. For the purpose of the present invention, it is only important that an electrode of some sort be included in the pacing lead. In some cases, the helix 10 may serve as the electrode.
Electrode head member 15' forms the proximal portion of the electrode head assembly and is provided with a circumferential groove 24', and with a cross bore 26'.
Groove 24' and cross core 26' are preferably filled with an implantable medical plastic 28' which may be either silicone rubber or polyurethane. A circular band of adhesive 30 surrounds plastic 28, and serves to seal the proximal end of plastic sleeve 16' and the distal end of an insulative sleeve 32' to the electrode head member 14'. Located within the proximal end of electrode head member 14' is a second bore
34', which receives the distal end of the coiled conductor 36'. Coiled conductor 36' is electrically and mechanically coupled to electrode head member 14' by means of a crimping core 38', in conjunction with inwardly directed crimps 40' in head member 14'. This mechanical connection mounts the conductor in fixed rotational relationship to the helix 10', allowing for transfer of torque to helix 10' via conductor 36'. The distal end of crimping core 38' is provided with a slot 42' located at its proximal end, which engages the distal end of a screwdriver tipped stylet 44' in fixed rotational relationship. An elongated insulative sheath 46' is mounted between insulative sleeve 32' and head member 14', and extends proximally to the proximal end of the lead. Sheath 46' is preferably made of an implantable elastoplastic such as silicone rubber or polyurethane. In bipolar embodiments, a second, ring electrode may be located on the lead body, coupled to a second coiled conductor. These optional structures are not illustrated.
In use, the distal end of the lead illustrated in FIG. 9 is advanced through the venous system, the superior vena cava and through the tricuspid valve and rotated so that helix 10' pierces the endocardium and is screwed into the interior wall of the heart. While screwing helix 10' into the heart tissue, it is desirable that stylet 44' be engaged with the slot 42' in crimping core 38' and that the stylet and the lead body be rotated simultaneously, so that both structures work together to apply torque to the electrode head member 14' and thus to the helix 10'. While the present invention is disclosed in the context of a pacing lead employing a fixed helix, it is believed that it may also be employed in the context of any lead employing an advanceable or rotatable helix of the type in which the fixation helix is rotationally fixed with regard to the distal end of the coiled conductor within the lead body. As such, the above embodiments should be considered exemplary, rather than limiting, in conjunction with the following claims. Thus, various methods and apparatus have been provided so that those skilled in the art can practice same. While at least one exemplary embodiment has been presented in the foregoing detailed description of the invention, it should be appreciated that a vast number of variations exist. It should also be appreciated that the exemplary embodiment or exemplary embodiments are only examples, and are not intended to limit the scope, applicability, or configuration of the invention in any way. Rather, the foregoing detailed description will provide those skilled in the art with a convenient road map for implementing an exemplary embodiment of the invention, it being understood that various changes may be made in the function and arrangement of elements described in an exemplary embodiment without departing from the scope of the invention as set forth in the appended claims and their legal equivalents.
1. A medical electrical lead for use with a bio-impedance-based implantation system, comprising: an elongated medical lead body having a proximal end and a distal end; at least one elongated electrical conductor disposed within the lead body; an aperture formed through a distal portion of said lead body, wherein said aperture is spaced from the distal end of said lead body and whereby the aperture exposes a portion of the elongated conductor.
2. A lead according to claim 1, wherein a retractable and extendable portion of the elongated conductor is disposed adjacent the aperture.
3. A lead according to claim 2, wherein the portion comprises a non- linear portion.
4. A lead according to claim 3, wherein the non- linear portion comprises a helical portion.
5. A lead according to claim 3, further comprising: a substantially flat structure coupled to the helical portion, and wherein the flat structure is slideably disposed within the lead body.
6. A lead according to claim 5, wherein the flat structure comprises a disk.
7. A lead according to claim 6, further comprising: a sealing member coupled to the disk so that when the helical portion is extended the sealing member substantially seals the aperture.
8. A lead according to claim 7, wherein the sealing member comprises a cylinder.
9. A lead according to claim 1, further comprising means for manipulating the retractable and extendable portion coupled to a portion of the proximal end of the lead body.
10. A lead according to claim 1, wherein the lead body comprises a temporary cardiac pacing lead.
11. A lead according to claim 10, further comprising: an elongated high voltage conductor disposed within the lead body; and a length of coiled conductor coupled to the high voltage conductor, wherein the coiled conductor is disposed around the periphery of the lead body.
12. A lead according to claim 1, further comprising: a plurality of apertures formed in a portion of the lead body, wherein each of the plurality of apertures exposes a portion of the elongated conductor; and a like plurality of sealing members, said sealing members adapted to simultaneously seal the plurality of apertures when manipulated from a portion of the proximal end of said lead body.
13. A lead according to claim 1, wherein the lead body comprises an insulative biocompatible material selected from a group consisting of:
14. A medical electrode lead, comprising: an elongated lead body including an elongated coiled conductor mounted within an elongated insulative sheath; an electrode head mounted to a distal end portion of said coiled conductor, and including a helical means for fixation of the electrode head adjacent body tissue to be stimulated, said helical fixation means mounted in a fixed rotational relationship to said coiled conductor; a connector means mounted at a proximal end of said coiled conductor for coupling to said coiled conductor, mounted in fixed rotational relationship to said coiled conductor; a stylet insertable within said coiled conductor; and means for mounting said stylet in fixed rotational relationship to both said connector means and said helical fixation means, wherein at least one aperture is disposed proximate said helical means for fixation, said at least one aperture spaced from the distal end of medical electrode lead.
15. A lead according to claim 14 wherein said elongated coiled conductor is mounted in fixed rotational relationship with said electrode head and with said elongated insulative sheath.
16. A lead according to claim 15 further comprising means for transferring torque from the proximal end of said elongated insulative sheath to said helix.
17. A lead according to claim 16 further comprising a stylet insertable within said elongated insulative sheath.
18. A lead according to claim 17 further comprising means for mounting said stylet in fixed rotational relationship to both said helix and said proximal end of said elongated insulative sheath.
19. A medical electrode lead comprising: an elongated insulative sheath having a proximal and distal end; an elongated conductor having a proximal end and a distal end and mounted within said elongated insulative sheath; an electrode head mounted to the distal end of said conductor, and including a helical means for fixation of said electrode head adjacent body tissue to be stimulated, said helical fixation means mounted in fixed rotational relationship to said electrode head; a connector assembly mounted to the proximal end of said elongated insulative sheath, and including an electrical connector coupled to the proximal end of said elongated conductor; a stylet insertable within said elongated insulative sheath; and means for mounting said stylet in fixed rotational relationship to both said connector assembly and said electrode head.
20. A lead according to claim 19, wherein said conductor comprises a coiled conductor and wherein said fixation means is mounted in fixed rotational relationship to said coiled conductor and wherein said connector assembly is mounted in fixed rotational relationship to said coiled conductor.
PCT/US2007/089087 2006-12-28 2007-12-28 Chronically-implantable active fixation medical electrical leads and related methods for non-fluoroscopic implantation WO2008108901A1 (en)
US88241306P true 2006-12-28 2006-12-28
US60/882,413 2006-12-28
US60/882,428 2006-12-28
US60/882,431 2006-12-28
US60/882,435 2006-12-28
US60/882,420 2006-12-28
US60/882,425 2006-12-28
EP07870059A EP2136706A1 (en) 2007-04-18 2007-12-28 Chronically-implantable active fixation medical electrical leads and related methods for non-fluoroscopic implantation
CN200780052606.8A CN101711125B (en) 2007-04-18 2007-12-28 For non-fluoroscopic long-term implantation of implantable medical electronics active fixed leads
US12/492,906 US8135467B2 (en) 2007-04-18 2009-06-26 Chronically-implantable active fixation medical electrical leads and related methods for non-fluoroscopic implantation
US12/492,906 Continuation US8135467B2 (en) 2006-12-28 2009-06-26 Chronically-implantable active fixation medical electrical leads and related methods for non-fluoroscopic implantation
WO2008108901A1 true WO2008108901A1 (en) 2008-09-12
WO2008108901A8 WO2008108901A8 (en) 2010-02-18
ID=39539591
PCT/US2007/089087 WO2008108901A1 (en) 2006-12-28 2007-12-28 Chronically-implantable active fixation medical electrical leads and related methods for non-fluoroscopic implantation
WO (1) WO2008108901A1 (en)
2007-12-28 WO PCT/US2007/089087 patent/WO2008108901A1/en active Application Filing
WO2008108901A8 (en) 2010-02-18
Ref document number: 200780052606.8
Ref document number: 07870059
Ref document number: 4308/DELNP/2009
Ref document number: 2007870059
2010-02-11 WPC Withdrawal of priority claims after completion of the technical preparations for international publication
Ref document number: 60/882,428
Ref document number: 60/882,425
Ref document number: 60/882,413
Ref document number: 60/882,431
Ref document number: 60/882,435
Ref document number: 60/882,420